Long-term outcome of repeated septal reduction therapy after
alcohol septal ablation for hypertrophic obstructive
cardiomyopathy: insight from the Euro-ASA registry

J 2020

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA et. al.

Basic information

Original name

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

Authors

VESELKA, Josef (203 Czech Republic, guarantor), Lothar FABER (276 Germany), Max LIEBREGTS (528 Netherlands), Robert COOPER (826 United Kingdom of Great Britain and Northern Ireland), Jaroslav JANUSKA (203 Czech Republic), Jan KREJČÍ (203 Czech Republic, belonging to the institution), Maciej DABROWSKI (616 Poland), Peter Riis HANSEN (208 Denmark), Hubert SEGGEWISS (276 Germany), Dieter HORSTKOTTE (276 Germany), Eva HANSVENCLOVA (203 Czech Republic), Henning BUNDGAARD (208 Denmark), Jurrien TEN BERG (528 Netherlands) and Morten Kvistholm JENSEN (208 Denmark)

Edition

Archives of Medical Science, Poland, Termedia Publishing House, 2020, 1734-1922

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30218 General and internal medicine

Country of publisher

Poland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 3.318

RIV identification code

RIV/00216224:14110/20:00116377

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.5114/aoms.2020.97969

UT WoS

000559104100030

Keywords in English

septal reduction therapy; alcohol septal ablation; hypertrophic obstructive cardiomyopathy

Abstract

V originále

Two-thirds of patients with hypertrophic cardiomyopathy (HCM) have a significant left ventricular outflow tract (LVOT) obstruction that may be treated with alcohol septal ablation (ASA) dependent on symptoms. However, some degree of obstruction may remain after ASA and if the patient remains symptomatic repeated septal reduction therapy (RSRT) may be indicated. The outcome of RSRT remains unknown. In this study, we sought to determine the long-term outcomes of patients treated with ASA or myectomy after previous ASA.

Citovat

VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Maciej DABROWSKI, Peter Riis HANSEN, Hubert SEGGEWISS, Dieter HORSTKOTTE, Eva HANSVENCLOVA, Henning BUNDGAARD, Jurrien TEN BERG and Morten Kvistholm JENSEN. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry. Archives of Medical Science. Poland: Termedia Publishing House, 2020, vol. 16, No 5, p. 1239-1242. ISSN 1734-1922. Available from: https://dx.doi.org/10.5114/aoms.2020.97969.

@article{1677999,
   author = {Veselka, Josef and Faber, Lothar and Liebregts, Max and Cooper, Robert and Januska, Jaroslav and Krejčí, Jan and Dabrowski, Maciej and Hansen, Peter Riis and Seggewiss, Hubert and Horstkotte, Dieter and Hansvenclova, Eva and Bundgaard, Henning and ten Berg, Jurrien and Jensen, Morten Kvistholm},
   article_location = {Poland},
   article_number = {5},
   doi = {http://dx.doi.org/10.5114/aoms.2020.97969},
   keywords = {septal reduction therapy; alcohol septal ablation; hypertrophic obstructive cardiomyopathy},
   language = {eng},
   issn = {1734-1922},
   journal = {Archives of Medical Science},
   title = {Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/},
   volume = {16},
   year = {2020}
}

TY  - JOUR
ID  - 1677999
AU  - Veselka, Josef - Faber, Lothar - Liebregts, Max - Cooper, Robert - Januska, Jaroslav - Krejčí, Jan - Dabrowski, Maciej - Hansen, Peter Riis - Seggewiss, Hubert - Horstkotte, Dieter - Hansvenclova, Eva - Bundgaard, Henning - ten Berg, Jurrien - Jensen, Morten Kvistholm
PY  - 2020
TI  - Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry
JF  - Archives of Medical Science
VL  - 16
IS  - 5
SP  - 1239-1242
EP  - 1239-1242
PB  - Termedia Publishing House
SN  - 17341922
KW  - septal reduction therapy
KW  - alcohol septal ablation
KW  - hypertrophic obstructive cardiomyopathy
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/
L2  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444689/
N2  - Two-thirds of patients with hypertrophic cardiomyopathy (HCM) have a significant left ventricular outflow tract (LVOT) obstruction that may be treated with alcohol septal ablation (ASA) dependent on symptoms. However, some degree of obstruction may remain after ASA and if the patient remains symptomatic repeated septal reduction therapy (RSRT) may be indicated. The outcome of RSRT remains unknown. In this study, we sought to determine the long-term outcomes of patients treated with ASA or myectomy after previous ASA.
ER  -

VESELKA, Josef, Lothar FABER, Max LIEBREGTS, Robert COOPER, Jaroslav JANUSKA, Jan KREJČÍ, Maciej DABROWSKI, Peter Riis HANSEN, Hubert SEGGEWISS, Dieter HORSTKOTTE, Eva HANSVENCLOVA, Henning BUNDGAARD, Jurrien TEN BERG and Morten Kvistholm JENSEN. Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry. \textit{Archives of Medical Science}. Poland: Termedia Publishing House, 2020, vol.~16, No~5, p.~1239-1242. ISSN~1734-1922. Available from: https://dx.doi.org/10.5114/aoms.2020.97969.

Detailed Information on Publication Record